Treatment of Post-Extraction Dehisced Socket - A Case Series Study
| Status: | Completed |
|---|---|
| Conditions: | Dental |
| Therapuetic Areas: | Dental / Maxillofacial Surgery |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 1/5/2019 |
| Start Date: | March 1, 2017 |
| End Date: | May 17, 2018 |
Clinical, Radiographic and Histologic Evaluation of a Novel Alveolar Ridge Reconstruction Approach in Post-Extraction Dehiscence Defects: A Case Series Study
PURPOSE The purpose of this case series is to clinically, radiographically and histologically
evaluate the treatment of dehiscence defects in extraction sockets using a minimally-invasive
GBR technique that involves the application of a particulate bone allograft and a
non-resorbable PTFE membrane.
METHODS Subjects with single-rooted teeth indicated for extraction and interested in future
implant therapy for tooth replacement will be recruited on the basis of an eligibility
criteria. A buccal or lingual dehiscence defect must strongly be suspected or confirmed upon
clinical examination in order for the subject to qualify for study inclusion. A cone-beam
computer tomography (CBCT) scan of the arch containing the tooth to be extracted will be
obtained prior to tooth extraction. Following minimally invasive tooth extraction and
debridement, the socket will be evaluated to verify the presence of a dehiscence defect
affecting at least 50% of the bony plate height. After creating a soft tissue 'pouch' using
tunneling instruments, a non-absorbable dense-PTFE (dPTFE) barrier membrane that will be
trimmed to a size and shape that would allow for complete extension over the existing defect
will be tucked between the mucosa and the alveolar bone. Then, the extraction socket will be
grafted with particulate allograft and the access to the socket will be sealed with an
extension of the membrane and an external cross mattress suture. Subjects will be recalled at
1, 2 and 5 weeks to monitor healing and assess the level of discomfort using a visual analog
scale at the end of each visit. At the 5-week visit, the membrane will be gently removed and
the exposed area will be left to heal by secondary intention. At 20 weeks after tooth
extraction a second CBCT will be obtained to radiographically evaluate the site for implant
placement. Bone volumetric reconstructions of the alveolar ridge at baseline and at 20 weeks
will be made using the CBCT data to assess changes affecting the bone housing. If the site
has healed adequately, implant placement will be planned at 24 weeks after tooth extraction.
A bone core biopsy will be obtained at the time of implant placement in order to
histologically analyze the characteristics of the grafted substrate. Upon implant placement
with primary stability a healing abutment will be placed and sutures will be given to achieve
primary wound closure, as necessary. Subjects will return for the final study visit at 2
weeks following implant placement to evaluate the healing prior to being referred back to the
restorative dentist.
evaluate the treatment of dehiscence defects in extraction sockets using a minimally-invasive
GBR technique that involves the application of a particulate bone allograft and a
non-resorbable PTFE membrane.
METHODS Subjects with single-rooted teeth indicated for extraction and interested in future
implant therapy for tooth replacement will be recruited on the basis of an eligibility
criteria. A buccal or lingual dehiscence defect must strongly be suspected or confirmed upon
clinical examination in order for the subject to qualify for study inclusion. A cone-beam
computer tomography (CBCT) scan of the arch containing the tooth to be extracted will be
obtained prior to tooth extraction. Following minimally invasive tooth extraction and
debridement, the socket will be evaluated to verify the presence of a dehiscence defect
affecting at least 50% of the bony plate height. After creating a soft tissue 'pouch' using
tunneling instruments, a non-absorbable dense-PTFE (dPTFE) barrier membrane that will be
trimmed to a size and shape that would allow for complete extension over the existing defect
will be tucked between the mucosa and the alveolar bone. Then, the extraction socket will be
grafted with particulate allograft and the access to the socket will be sealed with an
extension of the membrane and an external cross mattress suture. Subjects will be recalled at
1, 2 and 5 weeks to monitor healing and assess the level of discomfort using a visual analog
scale at the end of each visit. At the 5-week visit, the membrane will be gently removed and
the exposed area will be left to heal by secondary intention. At 20 weeks after tooth
extraction a second CBCT will be obtained to radiographically evaluate the site for implant
placement. Bone volumetric reconstructions of the alveolar ridge at baseline and at 20 weeks
will be made using the CBCT data to assess changes affecting the bone housing. If the site
has healed adequately, implant placement will be planned at 24 weeks after tooth extraction.
A bone core biopsy will be obtained at the time of implant placement in order to
histologically analyze the characteristics of the grafted substrate. Upon implant placement
with primary stability a healing abutment will be placed and sutures will be given to achieve
primary wound closure, as necessary. Subjects will return for the final study visit at 2
weeks following implant placement to evaluate the healing prior to being referred back to the
restorative dentist.
INCLUSION CRITERIA
- Provision of informed consent
- Age: 18 years or older
- Subjects with a single-rooted tooth indicated for extraction bounded by stable,
natural teeth
- Tooth planned for extraction must have a dehiscence defect in the surrounding bone,
observed clinically and/or radiographically, that affects at least 50% of the bone
height
- Subjects must be interested in replacing the tooth with a single implant-supported
fixed restoration
- Subjects must be able and willing to follow instructions related to the study
procedures
- Subjects must have read, understood and signed an informed consent form
EXCLUSION CRITERIA
- Mandibular incisors
- Subjects with a history of organ failure (e.g. liver, kidney)
- Subjects with severe hematologic disorders, such as hemophilia or leukemia
- Subjects with uncontrolled and/or severe metabolic bone diseases or disorders, such as
osteoporosis, thyroid disorders or Paget's disease
- Subjects taking any medication or supplement known to largely influence bone
metabolism, such as IV bisphosphonates, long-term history of oral bisphosphonates or
chronic intake of glucocorticoids
- Pregnant women (as indicated by positive serum HCG test) or nursing mothers
- Subjects with conditions that would result in compromised healing (e.g. poorly
controlled diabetes, active heavy tobacco use [>10 cigs/day])
- Subjects who, at the discretion of the investigators, would be unsuitable candidates
for the study due to safety, psychological or practical reasons (e.g. known allergies
to any product used for the study, limited mouth opening, etc.)
We found this trial at
1
site
Iowa City, Iowa 52242
Click here to add this to my saved trials
